Sort
25,944 grants matching “neurodegeneration”
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,587,671Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2022 · AG
Roles Of Brain Neuroimmune System In Neurodegeneration
$1,587,136Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
A Systems Approach to Targeting Innate Immunity in AD
$1,586,898Todd E. Golde · University Of Florida · U01 · FY2019 · AG
Role of the SYK-CARD9 signaling axis in Alzheimer's disease
$1,586,672John R Lukens · University Of Virginia · RF1 · FY2021 · AG
Roles of Cdk5 in neurodevelopment and neurodegeneration
$1,585,714Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2024 · NS
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$1,585,664Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2015 · MH
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,585,167Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2024 · AG
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,584,706Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2023 · AG
Combining Computational Methods, RDoC, and Big Neuroimaging Data to Understand Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Disease
$1,583,985Lisa D Nickerson · Mclean Hospital · RF1 · FY2025 · AG
Biology of Prion Protein and the TSE Diseases
$1,581,907Bruce Chesebro · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Function of ceramide in extracellular vesicle-mediated neurodegenerative disease
$1,581,504Erhard Bieberich · University Of Kentucky · RF1 · FY2022 · AG
La Jolla-Parkinson's Disease Center Grant
$1,579,586Stuart A Lipton · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · ES
CNS &Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,577,602Johns Hopkins University · P01 · FY2005 · MH
Functional Genetics of Susceptibility to Prions
$1,576,610Mc Laughlin Research Institute · P01 · FY2005 · NS
Neuron regenerative therapeutic, NNI-362, for first-in-human safety and PK for AD
$1,575,691Judith A Kelleher-Andersson · Neuronascent, Inc. · R01 · FY2018 · AG
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
$1,574,198Priya Palta · Columbia University Health Sciences · R01 · FY2019 · AG
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions
$1,573,956Sally Temple · Regenerative Research Foundation · U01 · FY2024 · AG
Fluorescent Redox Indicators to Image Oxidative Stress in Alzheimer's Disease
$1,573,788Huiwang Ai · University Of Virginia · RF1 · FY2022 · AG
PARKINSON'S DISEASE RESEARCH CENTER AT COLUMBIA
$1,573,609Columbia University Health Sciences · P50 · FY2000 · NS
ESTROGEN AND THE AGING BRAIN
$1,573,265Mount Sinai School Of Medicine Of Nyu · P01 · FY2003 · AG
Functional Genetics of Susceptibility to Prions
$1,572,933Mc Laughlin Research Institute · P01 · FY2004 · NS
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets
$1,572,782Aaron D. Gitler · Stanford University · U54 · FY2025 · NS
Sexual dimorphic cell type and connectivity atlases of the aging and AD mouse brains
$1,570,319Hong-Wei Dong · University Of California Los Angeles · R01 · FY2025 · AG
Functional Genetics of Susceptibility to Prions
$1,569,184Mc Laughlin Research Institute · P01 · FY2003 · NS
BOTANICAL CENTER FOR AGE-RELATED DISEASES
$1,569,184Purdue University West Lafayette · P50 · FY2002 · AT